A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
about
Rifaximin for maintenance therapy in antibiotic-dependent pouchitisDiagnosis and treatment of acute or persistent diarrheaMeta-analysis: oral or enteral nutritional supplementation in cirrhosisBrain-gut microbiome interactions and functional bowel disordersTravel Medicine for the Extreme TravelerPrevention of travelers' diarrhea with rifaximin in US travelers to MexicoPresident's address: travel medicine and principles of safe travelNoroviruses as a cause of traveler's diarrhea among students from the United States visiting MexicoNew Developments in Traveler's DiarrheaUse of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.Dissecting the evolutionary stealth of our flora against antibiotics.Chemoprophylaxis of Tropical Infectious Diseases.Bile acids improve the antimicrobial effect of rifaximin.Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial.Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS.Prevention and self-treatment of traveler's diarrhea.Expert review of the evidence base for prevention of travelers' diarrhea.Rifaximin for the treatment of acute infectious diarrheaFuture novel therapeutic agents for Clostridium difficile infection.Recent advances in small bowel diseases: Part I.Rifaximin: a review of its use in the management of traveller's diarrhoea.Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis.Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic.Prevention and treatment of traveler's diarrhea. Focus on antimicrobial agents.Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.Clostridium difficile infection: new insights into management.Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseasesPCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea.Systematic review: prevention of travellers' diarrhoea.The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea.Systematic review: the epidemiology and clinical features of travellers' diarrhoea.Clostridium difficile infection: management strategies for a difficult disease.Prophylaxis for travelers' diarrhea.Travellers' diarrhoea - pros and cons of different prophylactic measures.Rifaximin therapy of irritable bowel syndrome.Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea.Biologic properties and clinical uses of rifaximin.Rifaximin: recent advances in gastroenterology and hepatologyEfficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials.Challenges and opportunities in the management of Clostridium difficile infection.
P2860
Q21261868-39D134F0-4A56-4E9A-A71C-117159E1BC28Q24654895-29BC5F63-92A9-4A45-8B5A-6578A8490EA1Q27002659-E24CAF77-FF45-4100-AE9F-A7027BF98AD5Q27014531-1CC05EDA-94A4-4724-9DD7-161367D1C46DQ27480972-5C382386-DC88-4E41-B407-2FC773EF5049Q28280394-F32FBA70-1657-4496-9492-430F0145B8C7Q28384463-1E562080-B683-4FE1-81BD-B3F228703B96Q28387005-BC50EAA9-7244-4567-92B0-1CFA3EA281FAQ28387036-438E5988-A57D-4BD2-AADA-7113C80C27D1Q30248562-B7AF683A-6FBB-4C9B-B0A0-92A631863517Q30457450-F07492A3-85D1-4E39-B9EB-99A291C429AFQ33664324-6B047511-A03D-40E1-BE0E-A1C7CFD558AEQ34108534-EE0112B1-7824-4280-BC39-D6E112E15098Q34409185-35231CED-F90E-491A-A145-FB5F0C3EFB39Q34579745-63ED69C5-66EE-44F7-B89B-99C68356597FQ34974972-1C13EECE-90B8-47FA-B9AB-EC01631B3CBCQ34987670-9DB6CA34-5DA2-4C64-925C-EBD27E3E9D54Q35090413-2C4DEE60-A56F-418D-BB81-6757D1A5DF6BQ35175136-778996E0-8231-4A3B-850D-3805A071786CQ36093331-B05916F7-2263-498C-821F-29A2C7514B02Q36214684-CC72E20F-B54A-4180-986C-E65F09F5B3E4Q36233121-885FA7DF-BA73-42EB-B401-1223FB1ABCF8Q36404922-431F56BC-B305-4074-BE50-D5C2D24ED3C0Q36404962-7206D723-327A-47EE-B16E-0B0658A053ADQ36482832-58849CCF-CF88-455E-9C7C-1D973258703EQ36523440-A0C59BEB-BC78-4897-B660-D210B4188B90Q36533648-3842DD82-6A6B-40FF-B8B0-3362D3B981F3Q36747668-02147C8E-E786-46F6-BC2F-DBE8C78FC197Q37088561-65BF5FEF-ECF0-4135-ACB1-ADD8BBEF13A8Q37412963-5B648D74-3DC1-45E6-8F6B-7B702CA2EE5BQ37458962-78FDA05D-BDC8-49C9-AFF5-1894195D224FQ37519138-0349E68E-AD3B-4C30-8C94-9A4A9A80EB9CQ37554879-4B87F4D7-2D2E-4304-917D-BD8AC84C5775Q37633392-C9B916A9-E870-446E-98EE-4A253CF74E1AQ37704526-187179D6-7DCE-4F2E-9788-ED9A1457EB62Q37717744-7E1E719E-17A3-4953-AC84-5FEFE43FCC1FQ37827877-E268566B-0BF3-45EA-ADF6-A0E2C92B6CDAQ38074951-AE3B31C0-7640-4739-8161-EEB43AE9152FQ38078988-F8D84A44-8B0B-4D8A-A256-B1365021F5B6Q38228162-C55FB4A3-84CF-40F3-BD0F-23E372E85F72
P2860
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A randomized, double-blind, pl ...... o prevent travelers' diarrhea.
@en
type
label
A randomized, double-blind, pl ...... o prevent travelers' diarrhea.
@en
prefLabel
A randomized, double-blind, pl ...... o prevent travelers' diarrhea.
@en
P2093
P1476
A randomized, double-blind, pl ...... o prevent travelers' diarrhea.
@en
P2093
Charles D Ericsson
Francisco Javier de la Cabada
Francisco Martinez-Sandoval
Margaret W DuPont
Pablo C Okhuysen
Zhi-Dong Jiang
P304
P356
10.7326/0003-4819-142-10-200505170-00005
P407
P577
2005-05-01T00:00:00Z